Lung Cancer TALK: A Review of Data from the IASLC 2020 World Conference on Lung Cancer - Episode 6

WCLC Updates in Small Cell Lung Cancer

March 5, 2021

Stephen Liu, MD, Georgetown Lombardi Comprehensive Cancer Center, Sarah Goldberg, MD, MPH, Yale School of Medicine, Benjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Heather A. Wakelee, MD, Stanford University Medical Center

Panelists provide first impressions on recent clinical trials in the treatment of small cell lung cancer and comment on the safety and efficacy of study treatments.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC

EP. 2: WCLC Updates on the Emergence of ADCs in NSCLC

EP. 3: WCLC Updates in Immunotherapy for NSCLC

EP. 4: WCLC Updates in Neoadjuvant Therapy for NSCLC

EP. 5: WCLC Updates in Locally Advanced NSCLC

Now Viewing

EP. 6: WCLC Updates in Small Cell Lung Cancer

Data from the following clinical trials are discussed:

P15.01 - AMG 757, a Half-life Extended Bispecific T-Cell Engager (HLE BiTE® Immune Therapy) Targeting DLL3, for the Treatment of Small Cell Lung Cancer
OA11.04 - Lurbinectedin With Irinotecan in Relapsed Small Cell Lung Cancer. Results From the Expansion Stage of a Phase I/II Trial